Robert Scott reports a stock award at ARQT
By AlphaYouPublished Form 4
SCOTT ROBERT A
Reporting filer
Robert Scott reports a stock award, not an open-market purchase or sale, in Arcutis Biotherapeutics, Inc.. Form 4 filed Oct 28, 2026 lists 3 entries.
- Disclosed
- Oct 28, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | SCOTT ROBERT A | 2026-10-23 | A | Grant or award | 2819 | 0 | 2,819 | 5 days | Filed terms
|
| Stock Option (right to buy) (derivative) | SCOTT ROBERT A | 2026-10-23 | A | Grant or award | 20507 | 0 | 20,507 | 5 days | Filed terms
|
| Stock Option (right to buy) (derivative) | SCOTT ROBERT A | 2026-10-23 | A | Grant or award | 8663 | 0 | 8,663 | 5 days | Filed terms
|
Common Stock
- Owner
- SCOTT ROBERT A
- Date
- 2026-10-23
- Code
- A
- Action
- Grant or award
- Quantity
- 2819
- Price
- 0
- Following holdings
- 2,819
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-23
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 2819
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 2819
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- SCOTT ROBERT A
- Date
- 2026-10-23
- Code
- A
- Action
- Grant or award
- Quantity
- 20507
- Price
- 0
- Following holdings
- 20,507
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 31.20
- transaction Date: 2026-10-23
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 20507
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F2
- expiration Date: 2036-10-23
- underlying Security Title: Common Stock
- underlying Security Shares: 20507
- shares Owned Following Transaction: 20507
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- SCOTT ROBERT A
- Date
- 2026-10-23
- Code
- A
- Action
- Grant or award
- Quantity
- 8663
- Price
- 0
- Following holdings
- 8,663
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 31.20
- transaction Date: 2026-10-23
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 8663
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- expiration Date: 2036-10-23
- underlying Security Title: Common Stock
- underlying Security Shares: 8663
- shares Owned Following Transaction: 8663
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- SCOTT ROBERT A: Director.
- F1: Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director of the Company. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.
- F2: 1/3 each of the underlying shares subject to the option vest and become exercisable on the first annual anniversary of October 23, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the non-employee director's continued service through each applicable vesting date.
- F3: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.